SignalFDA/Bio

THIS TEST SCREENS FOR 50 CANCERS — BUT WHETHER MEDICARE AND OTHER HEALTH INSURERS WILL COVER IT HINGES ON FDA APPROVAL - MARKETWATCH

Medicare coverage for a 50-cancer screening test hinges on pending FDA approval.

What changed

Medicare coverage for a 50-cancer screening test hinges on pending FDA approval.

Why it matters

Medicare coverage for a 50-cancer screening test hinges on pending FDA approval. — impact context not separately stored; see What changed.

Sources